Skip to main content
. 2017 Feb 6;12(2):e0171320. doi: 10.1371/journal.pone.0171320

Table 1. Study variables and description of the sample.

Variables (N = 375) Categories n %
Sociodemographic variables      
Age (years) 65–69 86 22.9
  70–74 99 26.4
  75–79 109 29.1
  ≥80 81 21.6
Sex Male 137 36.5
  Female 238 63.5
Residence Costa del Sol 292 77.9
  North Malaga 83 22.1
Cohabitation Alone 85 22.8
  Accompanied 290 77.2
Socioeconomic level Low 19 5.1
  Middle 338 90.1
  High 18 4.8
Social assessment (Gijón scale)1 Low or normal 314 83.7
  Intermediate 61 16.3
Clinical variables      
BADL (Barthel test)2 Independent 257 68.5
  Mild dependence 50 13.3
  Moderate dependence 68 18.2
Mental assessment (Pfeiffer test)3 Normal 366 97.6
  Mild impairment 9 2.4
Emotional state (Goldberg scale)4 Anxiety 227 60.5
  Depression 128 34.1
Main pathologies Hypertension 330 88
  Dyslipidemia 244 65.1
  Diabetes 197 52.5
ER5 visits (previous 12 months) No 172 45.9
  Yes 203 54.1
Medication variables      
Number of medicines ≥10 196 52.3
  >10 179 47.7
Medication adherence (Morisky-Green) Adherence 194 51.7
  Nonadherence 181 48.3
Drug-related problems (P1, P2)6 No 63 16.8
  Yes 312 83.2
C7.1- Patient forgot to use/take drug No 216 57.6
  Yes 159 42.4
C.5.5- Wrong drug taken No 363 96.8
  Yes 12 3.2
C5.6- Drug abused (unregulated overuse) No 187 49.9
  Yes 188 50.1
C5.1- Inappropriate timing of administration and/or dosing intervals No 142 37.9
  Yes 233 62.1
Different brands of medicines No 59 15.7
  Yes 316 84.3
Identifies medicines with disease No 76 20.3
  Yes 299 79.7
Quality of life      
Health perception today (about 1 year ago) Better 63 16.8
  Equal 142 37.9
  Worse 170 45.3
EuroQol Visual Analogue Scale (EQ-VAS) <60 201 53.6
  ≥60 174 46.4

1Gijón scale (Social risk): < 10: normal or low; 10–16: intermediate; >16: high.

2BADL: Basic activities of daily living. Barthel scale: independent (100); mild dependence (91–99); moderate dependence (61–90).

3Pfeiffer: normal (0–2), mild impairment (3–4).

4Goldberg: anxiety subscale (≥4 risk of anxiety); depression subscale (≥6 risk of depression).

5ER: Emergency room.

6Drug-related problems (DRP) according to PCNE classification V6.2. P1: Treatment effectiveness (There is a (potential) problem with the (lack of) effect of the pharmacotherapy); P2: Adverse reactions (Patient suffers, or will possibly suffer, from an adverse drug event).